DEFRA have reviewed the available technologies for gene containment and ACRE support their findings. In essence, all containment strategies have weaknesses and post-release monitoring would almost always be required.
Evidence from:
ACRE Advice February 2006.
“Advice on the implications of findings in a Defra-funded desk study: ‘Technologies for biological containment of GM and non-GM crops’”
The report lists the ways in which containment can be made more likely. This should be of assistance in insurance risk assessment.
Further detail: